Alison Innes

Statistics

Publications

Citations

1.6K

H-Index

Active since

2004

Affiliations

UCB Pharma (United Kingdom)(Current)

Biogen (United States)

Addenbrooke's Hospital

University of the Witwatersrand

Sahyadri Hospital

Alison Innes is an author at UCB Pharma (United Kingdom) specializing in medicine, inflammatory bowel disease therapy, and inflammatory bowel disease.

Publications per year

2004–2019

Publications

A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease

Stefan Schreiber, Paul Rutgeerts, Richard N. Fedorak et al. · Gastroenterology · 2005 · 581 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 352 citations · Full text

Medicine, Hematology, Immunology +14

The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial

David Beard, Loretta Davies, Jonathan Cook et al. · The Lancet · 2019 · 302 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +15

Intravenous CDP870, a PEGylated Fab′ fragment of a humanized antitumour necrosis factor antibody, in patients with moderate‐to‐severe Crohn's disease: an exploratory study

Trevor A. Winter, John Wright, Subrata Ghosh et al. · Alimentary Pharmacology & Therapeutics · 2004 · 127 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis

Robert J. Hopkins, Brett Pleune, Gloria S. Sivko et al. · Clinical and Vaccine Immunology · 2013 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 9